Publications by Network Members
The Network classifies it's studies into two categories: SEAICRN Studies and Partnership Studies.
The following list of publications shows studies conducted by SEAICRN members. However, these studies are not supported by SEAICRN.
Recent Publications by SEAICRN Members
1. Wuthiekanun, V., et al., Perasafe, Virkon and bleach are bactericidal for Burkholderia pseudomallei, a select agent and the cause of melioidosis. J Hosp Infect, 2011. 77(2): p. 183-4.
2. Thai, K.T., et al., High incidence of peripheral blood plasmacytosis in patients with dengue virus infection. Clin Microbiol Infect, 2011. 17(12): p. 1823-8.
3. Suhaila, M., et al., Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children. Pediatr Infect Dis J, 2011. 30(7): p. 625-7.
4. Saralamba, S., et al., Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A, 2011. 108(1): p. 397-402.
5. Safika, I., T.P. Johnson, and J.A. Levy, A venue analysis of predictors of alcohol use prior to sexual intercourse among female sex workers in Senggigi, Indonesia. Int J Drug Policy, 2011. 22(1): p. 49-55.
6. Punpanich, W., et al., Development of a culturally appropriate health-related quality of life measure for human immunodeficiency virus-infected children in Thailand. J Paediatr Child Health, 2011. 47(1-2): p. 27-33.
7. Nakwan, N., et al., Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol, 2011. 46(1): p. 60-6.
8. Lumbiganon, P., et al., Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr, 2011. 56(4): p. 365-71.
9. Kerdpanich, A., et al., Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 degrees C for seven days. Hum Vaccin, 2011. 7(1): p. 74-80.
10. Kariminia, A., et al., Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol, 2011. 40(1): p. 15-24.
11. Imwong, M., et al., Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax. J Infect Dis, 2011. 203(2): p. 207-10.
12. Hayden, F.G. and M.D. de Jong, Emerging influenza antiviral resistance threats. J Infect Dis, 2011. 203(1): p. 6-10.
13. Bui, H.M., et al., Social and environmental determinants of malaria in space and time in Viet Nam. Int J Parasitol, 2011. 41(1): p. 109-16.
14. Baird, J.K. and C. Surjadjaja, Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol, 2011. 27(1): p. 11-6.
15. Writing Committee of the, W.H.O.C.o.C.A.o.P.I., et al., Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med, 2010. 362(18): p. 1708-19.
16. Wongsawat, J. and K. Chokephaibulkit, Implication of pneumococcal conjugate vaccines to public health: Thailand perspective. J Med Assoc Thai, 2010. 93 Suppl 5: p. S53-60.
17. Wongprasit, P., et al., Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy. AIDS Patient Care STDS, 2010. 24(4): p. 205-9.
18. Wiria, A.E., et al., Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis, 2010. 10: p. 77.
19. White, N.J., Artemisinin resistance--the clock is ticking. Lancet, 2010. 376(9758): p. 2051-2.
20. Wells, T.N., J.N. Burrows, and J.K. Baird, Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol, 2010. 26(3): p. 145-51.
21. Wangdi, K., et al., Development of temporal modelling for forecasting and prediction of malaria infections using time-series and ARIMAX analyses: a case study in endemic districts of Bhutan. Malar J, 2010. 9: p. 251.
22. Vatanavicharn, N., et al., An infant with cartilage-hair hypoplasia due to a novel homozygous mutation in the promoter region of the RMRP gene associated with chondrodysplasia and severe immunodeficiency. J Appl Genet, 2010. 51(4): p. 523-8.
23. Vanprapar, N., et al., A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. Pediatr Infect Dis J, 2010. 29(10): p. 940-4.
24. van Trijp, M.J., et al., Genotypes, superantigen gene profiles, and presence of exfoliative toxin genes in clinical methicillin-susceptible Staphylococcus aureus isolates. Diagn Microbiol Infect Dis, 2010. 66(2): p. 222-4.
25. van der Windt, G.J., et al., Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis). PLoS Negl Trop Dis, 2010. 4(8).
26. van de Beek, D., et al., Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol, 2010. 9(3): p. 254-63.
27. Valecha, N., et al., An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS One, 2010. 5(7): p. e11880.
28. Uttayamakul, S., et al., Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther, 2010. 7: p. 8.
29. Tricou, V., et al., A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis, 2010. 4(8): p. e785.
30. Thwaites, G.E. and G. United Kingdom Clinical Infection Research, The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation. PLoS One, 2010. 5(12): p. e14170.
31. Thanh, T.T., et al., A real-time RT-PCR for detection of clade 1 and 2 H5N1 influenza A virus using locked nucleic acid (LNA) TaqMan probes. Virol J, 2010. 7: p. 46.
32. Thai, K.T., et al., Clinical, epidemiological and virological features of Dengue virus infections in Vietnamese patients presenting to primary care facilities with acute undifferentiated fever. J Infect, 2010. 60(3): p. 229-37.
33. Thai, K.T., et al., Dengue dynamics in Binh Thuan province, southern Vietnam: periodicity, synchronicity and climate variability. PLoS Negl Trop Dis, 2010. 4(7): p. e747.
34. Tanomsing, N., et al., Accurate and sensitive detection of Plasmodium species in humans by use of the dihydrofolate reductase-thymidylate synthase linker region. J Clin Microbiol, 2010. 48(10): p. 3735-7.
35. Takeuchi, R., et al., Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J, 2010. 9: p. 308.
36. Syhavong, B., et al., The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos. Trans R Soc Trop Med Hyg, 2010. 104(7): p. 475-83.
37. Sutherland, C.J., et al., Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis, 2010. 201(10): p. 1544-50.
38. Suntarattiwong, P., et al., Clinical performance of a rapid influenza test and comparison of nasal versus throat swabs to detect 2009 pandemic influenza A (H1N1) infection in Thai children. Pediatr Infect Dis J, 2010. 29(4): p. 366-7.
39. Stepniewska, K., et al., In vivo parasitological measures of artemisinin susceptibility. J Infect Dis, 2010. 201(4): p. 570-9.
40. Srifuengfung, S., et al., Fluoroquinolone resistance in Streptococcus pneumoniae from a university hospital, Thailand. J Med Assoc Thai, 2010. 93 Suppl 5: p. S35-9.
41. Srifuengfung, S., et al., A description of antimicrobial susceptibility of Streptococcus pneumoniae-Siriraj Hospital, Thailand: 2008. J Med Assoc Thai, 2010. 93 Suppl 5: p. S27-34.
42. Srifuengfung, S. and K. Chokephaibulkit, Detection of bacterial antigen in cerebrospinal fluid in patients with bacterial meningitis: a literature review. J Med Assoc Thai, 2010. 93 Suppl 5: p. S71-5.
43. Srifeungfung, S., et al., Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Vaccine, 2010. 28(19): p. 3440-4.
44. Sonthayanon, P., et al., High rates of homologous recombination in the mite endosymbiont and opportunistic human pathogen Orientia tsutsugamushi. PLoS Negl Trop Dis, 2010. 4(7): p. e752.
45. Smithuis, F., et al., Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis, 2010. 10(10): p. 673-81.
46. Siripassorn, K., et al., Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting. AIDS Res Hum Retroviruses, 2010. 26(2): p. 139-48.
47. Puthanakit, T., et al., HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. HIV Med, 2010. 11(9): p. 565-72.
48. Punpanich, W., et al., Health-related Quality of Life of Thai children with HIV infection: a comparison of the Thai Quality of Life in Children (ThQLC) with the Pediatric Quality of Life Inventory version 4.0 (PedsQL 4.0) Generic Core Scales. Qual Life Res, 2010. 19(10): p. 1509-16.
49. Pukrittayakamee, S., et al., A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg, 2010. 82(4): p. 542-7.
50. Price, E.P., et al., Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis. PLoS Pathog, 2010. 6(1): p. e1000725.
51. Preechapornkul, P., et al., Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors. Southeast Asian J Trop Med Public Health, 2010. 41(4): p. 761-9.
52. Piola, P., et al., Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis, 2010. 10(11): p. 762-9.
53. Phung, T.B., et al., Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam--genotypes B4 and C1 predominate. J Med Virol, 2010. 82(8): p. 1327-33.
54. Phu, N.H., et al., Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J, 2010. 9: p. 97.
55. Parwati, I., R. van Crevel, and D. van Soolingen, Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis, 2010. 10(2): p. 103-11.
56. Parwati, I., et al., Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis, 2010. 201(4): p. 553-7.
57. Parry, C.M., et al., Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother, 2010. 54(12): p. 5201-8.
58. Pagnarith, Y., et al., Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg, 2010. 82(6): p. 1106-12.
59. O'Riordan, S., et al., Large scale screening for haemoglobin disorders in southern Vietnam: implications for avoidance and management. Br J Haematol, 2010. 150(3): p. 359-64.
60. Niederer, H.A., et al., Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet, 2010. 19(16): p. 3282-94.
61. Nguyen Thanh, L., et al., Laparoscopic repair for choledochal cyst: lessons learned from 190 cases. J Pediatr Surg, 2010. 45(3): p. 540-4.
62. Nguyen, N.T., et al., The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam. PLoS Negl Trop Dis, 2010. 4(6): p. e702.
63. Nguyen, H.H., Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis, 2010. 51 Suppl 2: p. S220-3.
64. Nga, T.V., et al., The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens. BMC Infect Dis, 2010. 10: p. 125.
65. Nakwan, N., N. Nakwan, and K. Chokephaibulkit, Pasteurella multocida infection in the neonates. Pediatr Infect Dis J, 2010. 29(2): p. 192.
66. Nakamura, K., et al., Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis, 2010. 50(7): p. e47-9.
67. Mwesigwa, J., et al., Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother, 2010. 54(1): p. 52-9.
68. Mu, J., et al., Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet, 2010. 42(3): p. 268-71.
69. Monteerarat, Y., et al., Induction of TNF-alpha in human macrophages by avian and human influenza viruses. Arch Virol, 2010. 155(8): p. 1273-9.
70. Medana, I.M., et al., Induction of the vascular endothelial growth factor pathway in the brain of adults with fatal falciparum malaria is a non-specific response to severe disease. Histopathology, 2010. 57(2): p. 282-94.
71. McGready, R., et al., Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings. Am J Trop Med Hyg, 2010. 83(6): p. 1322-9.
72. McGready, R., et al., Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border. PLoS Negl Trop Dis, 2010. 4(11): p. e888.
73. Mayxay, M., et al., A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos. Am J Trop Med Hyg, 2010. 83(6): p. 1221-9.
74. Maude, R.J., et al., The role of mathematical modelling in guiding the science and economics of malaria elimination. Int Health, 2010. 2(4): p. 239-46.
75. Manosuthi, W., et al., Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. AIDS, 2010. 24(3): p. 411-6.
76. Manosuthi, W., et al., Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine. AIDS Res Hum Retroviruses, 2010. 26(6): p. 609-11.
77. Luke, T.C., et al., Hark back: passive immunotherapy for influenza and other serious infections. Crit Care Med, 2010. 38(4 Suppl): p. e66-73.
78. Lourens, C., et al., Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J, 2010. 9: p. 375.
79. Limmathurotsakul, D., et al., Burkholderia pseudomallei is spatially distributed in soil in northeast Thailand. PLoS Negl Trop Dis, 2010. 4(6): p. e694.
80. Limmathurotsakul, D., et al., Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg, 2010. 82(6): p. 1113-7.
81. Limmathurotsakul, D., et al., Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One, 2010. 5(8): p. e12485.
82. Lee, V.J., et al., Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. BMC Infect Dis, 2010. 10: p. 164.
83. Lee, V.J., et al., Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med, 2010. 362(23): p. 2166-74.
84. Lee, V., et al., Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study. J Infect Dis, 2010. 202(9): p. 1319-26.
85. Lee, H.K., et al., Diagnostic testing for pandemic influenza in Singapore: a novel dual-gene quantitative real-time RT-PCR for the detection of influenza A/H1N1/2009. J Mol Diagn, 2010. 12(5): p. 636-43.
86. Le, V.T., et al., Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl Trop Dis, 2010. 4(10): p. e854.
87. Kositanont, U., et al., Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients. Viral Immunol, 2010. 23(3): p. 329-34.
88. Kiet, V.S., et al., Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol, 2010. 48(8): p. 2934-9.
89. Khor, C.C., et al., CISH and susceptibility to infectious diseases. N Engl J Med, 2010. 362(22): p. 2092-101.
90. Kerdpanich, A., et al., Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent. Hum Vaccin, 2010. 6(3).
91. Karema, C., et al., Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother, 2010. 54(1): p. 477-83.
92. Jin, J., et al., Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore. Ann Acad Med Singapore, 2010. 39(6): p. 453-9.
93. Imwong, M., et al., Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother, 2010. 54(7): p. 2886-92.
94. Ho, J., P.A. Tambyah, and D.L. Paterson, Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis, 2010. 23(6): p. 546-53.
95. Hansudewechakul, R., et al., Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database. J Acquir Immune Defic Syndr, 2010. 55(4): p. 503-9.
96. Hanson, J., et al., A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis, 2010. 50(5): p. 679-85.
97. Ha do, T., et al., Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells. J Ethnopharmacol, 2010. 131(2): p. 417-24.
98. Fox, A., et al., Influenza A H5N1 and HIV co-infection: case report. BMC Infect Dis, 2010. 10: p. 167.
99. Dung, N.T., et al., Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol, 2010. 184(12): p. 7281-7.
100. Dondorp, A.M., et al., Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol, 2010. 8(4): p. 272-80.
101. Dondorp, A.M., et al., Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet, 2010. 376(9753): p. 1647-57.
102. Choowongkomon, K., et al., Computational analysis of binding between malarial dihydrofolate reductases and anti-folates. Malar J, 2010. 9: p. 65.
103. Chokephaibulkit, K., et al., Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J, 2010. 29(12): p. 1111-7.
104. Chokephaibulkit, K., et al., A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children. Vaccine, 2010. 28(20): p. 3563-6.
105. Cheah, P.Y., et al., Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt. Int Health, 2010. 2(2): p. 123-9.
106. Chau, T.T., et al., Three adult cases of Listeria monocytogenes meningitis in Vietnam. PLoS Med, 2010. 7(7): p. e1000306.
107. Chau, T.N., et al., Clinical and virological features of Dengue in Vietnamese infants. PLoS Negl Trop Dis, 2010. 4(4): p. e657.
108. Chapman, S.J., et al., Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study. Crit Care, 2010. 14(6): p. R227.
109. Chapman, S.J., et al., NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immun, 2010. 11(4): p. 319-25.
110. Bunupuradah, T., et al., Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors. Int J Infect Dis, 2010. 14(4): p. e311-6.
111. Brouwer, A.E., et al., Cerebrospinal fluid HIV-1 viral load during treatment of cryptococcal Meningitis. J Acquir Immune Defic Syndr, 2010. 53(5): p. 668-9.
112. Boel, M., et al., Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border. PLoS Negl Trop Dis, 2010. 4(11): p. e887.
113. Bode, L.G., et al., Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med, 2010. 362(1): p. 9-17.
114. Blacksell, S.D., et al., Accuracy of AccessBio Immunoglobulin M and Total Antibody Rapid Immunochromatographic Assays for the Diagnosis of Acute Scrub Typhus Infection. Clin Vaccine Immunol, 2010. 17(2): p. 263-6.
115. Blacksell, S.D., et al., Accuracy of rapid IgM-based immunochromatographic and immunoblot assays for diagnosis of acute scrub typhus and murine typhus infections in Laos. Am J Trop Med Hyg, 2010. 83(2): p. 365-9.
116. Beigel, J.H., et al., Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. Antimicrob Agents Chemother, 2010. 54(6): p. 2431-6.
117. Awab, G.R., et al., Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial. Malar J, 2010. 9: p. 105.
118. Ashley, E.A., et al., Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria. Eur J Clin Pharmacol, 2010. 66(7): p. 705-12.
119. Anderson, T.J., et al., High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis, 2010. 201(9): p. 1326-30.